To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene INPPL1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
568 supporting clones for gene INPPL1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
TI_151757640   .a 1 to 755 809 to 56   tiling clone,   754/1030
(73 %)
0 diff
(100 %id)
BM717967 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 10 to 364 1 to 355   tiling clone,   355/355
(100 %)
0 diff
(100 %id)
Y14385 hippocampus .a 460 to 5192 8 to 4740 A1114G tiling clone,   4733/4743
(99 %)
8 diff
(99.9 %id)
AI888996 2 pooled tumors (clear cell type), Kidney .a 474 to 707 234 to 1       234/234
(100 %)
0 diff
(100 %id)
AI479557 Kidney .a 477 to 730 254 to 1       254/254
(100 %)
0 diff
(100 %id)
BC140853 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .a 517 to 4487 1 to 3971 exact tiling clone,   3971/3971
(100 %)
0 diff
(100 %id)
NM_001567.3   .a 517 to 5225 1 to 4709 exact RefSeq, AAA   4709/4709
(100 %)
0 diff
(100 %id)
BF002900 Prostate .a 746 to 1343 1 to 604     Submitted on the opposite strand 604/604
(100 %)
10 diff
(98.4 %id)
AA252822 germinal center B cell .a 748 to 1156 1 to 406     Submitted on the opposite strand 406/406
(100 %)
14 diff
(96.6 %id)
AA577391 colon, colon tumor RER+ .a 748 to 1209 1 to 460     Submitted on the opposite strand 460/460
(100 %)
14 diff
(97.0 %id)
AI077424   .a 748 to 1245 1 to 498     Submitted on the opposite strand 498/498
(100 %)
0 diff
(100 %id)
AI338454   .a 748 to 1266 1 to 519     Submitted on the opposite strand 519/519
(100 %)
2 diff
(99.7 %id)
AI971971 fibrotheoma, ovary .a 748 to 1244 1 to 497     Submitted on the opposite strand 497/497
(100 %)
0 diff
(100 %id)
AA279072 germinal center B cell .a 749 to 1117 1 to 364     Submitted on the opposite strand 364/364
(100 %)
13 diff
(96.5 %id)
TI_1968233455   .a 757 to 1860 1127 to 28       1100/1286
(85 %)
10 diff
(99.3 %id)
AA350852 brain .a 769 to 1087 1 to 318     Submitted on the opposite strand 319/318
(100 %)
8 diff
(97.5 %id)
AI276965 placenta .a 775 to 1251 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
AI370821   .a 775 to 1242 1 to 468     Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
AW044430 pooled .a 775 to 1251 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
AA824424 germinal center B cell .a 829 to 1125 1 to 296       296/296
(100 %)
5 diff
(98.4 %id)
BM148069 leukopheresis .a 849 to 1134 1 to 287       287/287
(100 %)
3 diff
(99.0 %id)
BF926559 nervous_tumor .a 855 to 1298 1 to 443       443/443
(100 %)
7 diff
(98.5 %id)
AA577256 colon, colon tumor RER+ .a 859 to 1028 1 to 170     Submitted on the opposite strand 170/172
(98 %)
1 diff
(99.5 %id)
CN279224 embryonic stem cells, cell lines H1, H7, andH9 .a 892 to 1308 1 to 417       417/417
(100 %)
0 diff
(100 %id)
BI770612 pooled lung and spleen .a 945 to 1890 947 to 1     Submitted on the opposite strand 947/947
(100 %)
17 diff
(98.3 %id)
TI_57183520   .a 945 to 1893 979 to 30     Submitted on the opposite strand 950/979
(97 %)
16 diff
(98.4 %id)
BE734585 choriocarcinoma, placenta .a 1002 to 1762 1 to 776       775/941
(82 %)
62 diff
(93.5 %id)
AL135036 melanoma (MeWo cell line) .a 1008 to 1612 24 to 629       606/629
(96 %)
8 diff
(98.8 %id)
TI_1968233457   .a 1058 to 2210 1163 to 18       1146/1289
(88 %)
11 diff
(99.2 %id)
CN279232 embryonic stem cells, cell lines H1, H7, andH9 .a 1061 to 1638 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
TI_1968235413   .a 1093 to 2286 12 to 1191     Submitted on the opposite strand 1180/1259
(93 %)
19 diff
(98.5 %id)
BI010454 lung_normal .a 1145 to 1676 10 to 545       538/548
(98 %)
27 diff
(95.1 %id)
CN279237 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1243 to 1952 1 to 711       711/711
(100 %)
4 diff
(99.5 %id)
CF135898 lymph .a 1249 to 1436 1 to 188       188/188
(100 %)
7 diff
(96.3 %id)
CN279229 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1291 to 2028 1 to 741       741/741
(100 %)
5 diff
(99.4 %id)
CN279235 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1307 to 1914 6 to 614       609/614
(99 %)
2 diff
(99.7 %id)
CA391936 eye, RPE/choroid .a 1308 to 1961 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
BG748751 eye, normal pigmented retinal epithelium .a 1358 to 2085 1 to 736       736/736
(100 %)
14 diff
(98.1 %id)
BG752662 eye, normal pigmented retinal epithelium .a 1358 to 1938 1 to 600       422/841
(50 %)
12 diff
(98.6 %id)
BG752843 eye, normal pigmented retinal epithelium .a 1358 to 2194 1 to 842       842/842
(100 %)
10 diff
(98.9 %id)
BF925286 nervous_tumor .a 1414 to 1851 443 to 6     Submitted on the opposite strand 438/454
(96 %)
3 diff
(99.4 %id)
BP232548 muscle .a 1421 to 2003 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BG819019 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1428 to 2093 1 to 665       665/704
(94 %)
20 diff
(97.2 %id)
TI_154150407   .a 1461 to 2087 81 to 711       631/847
(74 %)
31 diff
(96.4 %id)
BI062985 uterus_tumor .a 1471 to 2011 541 to 1       541/541
(100 %)
0 diff
(100 %id)
BG011571 placenta_normal .a 1472 to 1859 414 to 29       385/414
(92 %)
2 diff
(99.6 %id)
Z42538 brain, total brain .a 1562 to 1852 1 to 291       291/291
(100 %)
2 diff
(99.4 %id)
BG392587 embryonal carcinoma, cell line, testis .a 1564 to 2090 1 to 527       527/527
(100 %)
2 diff
(99.7 %id)
BG315508   .a 1601 to 1924 324 to 1       324/331
(97 %)
4 diff
(98.8 %id)
BU149336 epidermoid carcinoma, cell line, lung .a 1628 to 2442 1 to 825       825/868
(95 %)
10 diff
(98.9 %id)
BU159814 eye, retinoblastoma .a 1650 to 1958 1 to 315       315/1177
(26 %)
9 diff
(99.3 %id)
BF892146 marrow .a 1684 to 2064 17 to 397       381/397
(95 %)
6 diff
(98.5 %id)
AL561585 B cells from Burkitt lymphoma .a 1688 to 2459 1 to 781       781/805
(97 %)
12 diff
(98.6 %id)
BE839239 prostate_normal .a 1691 to 1920 233 to 7       227/238
(95 %)
0 diff
(100 %id)
BE839249 prostate_normal .a 1691 to 1860 194 to 25       170/200
(85 %)
0 diff
(100 %id)
BI831216 brain, medulla .a 1708 to 2092 1 to 384       384/384
(100 %)
3 diff
(99.3 %id)
BI062983 uterus_tumor .a 1773 to 2010 239 to 2       238/239
(99 %)
2 diff
(99.2 %id)
AA252855 germinal center B cell .a 1784 to 2189 418 to 12   AAA Submitted on the opposite strand 407/418
(97 %)
2 diff
(99.6 %id)
DB229952 trachea .a 1784 to 2384 2 to 602   capped   601/601
(100 %)
0 diff
(100 %id)
DB076659 testis .a 1789 to 2348 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA457804 tongue, tumor tissue .a 1843 to 2302 2 to 461   capped   460/460
(100 %)
0 diff
(100 %id)
DA457810 tongue, tumor tissue .a 1843 to 2399 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BF843835 head_neck .a 1850 to 2379 574 to 42     Submitted on the opposite strand 534/634
(84 %)
25 diff
(96.1 %id)
AU134190 ovary, tumor tissue .a 1853 to 2428 7 to 582   capped   576/588
(97 %)
6 diff
(99.0 %id)
CN279231 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1858 to 2344 1 to 487       487/487
(100 %)
5 diff
(99.0 %id)
BF229923 colon_est .a 1860 to 2229 15 to 384       370/384
(96 %)
8 diff
(98.0 %id)
BF761999 colon_est .a 1860 to 2221 38 to 399       362/399
(90 %)
8 diff
(98.0 %id)
CD612013   .a 1863 to 2550 1 to 695       695/695
(100 %)
12 diff
(98.3 %id)
CD612015   .a 1863 to 2591 1 to 725       725/725
(100 %)
13 diff
(98.3 %id)
CD612017   .a 1863 to 2560 1 to 698       698/698
(100 %)
7 diff
(99.0 %id)
CD612018   .a 1863 to 2637 773 to 1       773/773
(100 %)
11 diff
(98.6 %id)
CD612019   .a 1863 to 1964 1 to 102       102/103
(99 %)
4 diff
(96.2 %id)
CD612020   .a 1863 to 2637 778 to 1       778/781
(99 %)
5 diff
(99.4 %id)
CD612021   .a 1863 to 2536 1 to 678       676/678
(99 %)
11 diff
(98.4 %id)
CD612022   .a 1863 to 2637 775 to 1       775/775
(100 %)
2 diff
(99.8 %id)
CD612023   .a 1863 to 2618 1 to 753       753/774
(97 %)
13 diff
(98.4 %id)
CD612025   .a 1863 to 2384 1 to 522       522/522
(100 %)
3 diff
(99.5 %id)
CD612027   .a 1863 to 2335 1 to 473       473/494
(95 %)
3 diff
(99.4 %id)
CD612028   .a 1863 to 2335 491 to 20       472/491
(96 %)
3 diff
(99.4 %id)
CD612029   .a 1863 to 2335 1 to 473       473/494
(95 %)
4 diff
(99.2 %id)
CD612030   .a 1863 to 2335 491 to 21       473/491
(96 %)
5 diff
(99.0 %id)
CD612031   .a 1863 to 2335 1 to 474       474/495
(95 %)
6 diff
(98.8 %id)
CD612032   .a 1863 to 2146 283 to 1       283/283
(100 %)
4 diff
(98.6 %id)
CD612033   .a 1863 to 2335 1 to 473       473/494
(95 %)
4 diff
(99.2 %id)
CD612034   .a 1863 to 2335 493 to 21       473/493
(95 %)
4 diff
(99.2 %id)
BQ708035 Spleen .a 1866 to 2705 1 to 841       841/968
(86 %)
24 diff
(97.6 %id)
BM558180 duodenal adenocarcinoma, cell line, small intestine .a 1870 to 2194 22 to 346       325/1349
(24 %)
8 diff
(99.5 %id)
CD612024   .a 1871 to 2635 764 to 1       764/768
(99 %)
1 diff
(99.9 %id)
CD612026   .a 1871 to 2637 767 to 1       767/767
(100 %)
3 diff
(99.7 %id)
BG170678 hypernephroma, cell line, Kidney .a 1871 to 2090 1 to 220       220/220
(100 %)
4 diff
(98.2 %id)
DB149667 thymus .a 1888 to 2456 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
CD612014   .a 1890 to 2590 706 to 8       699/706
(99 %)
14 diff
(98.1 %id)
CD612016   .a 1901 to 2620 736 to 6       740/749
(98 %)
74 diff
(90.2 %id)
CO392801 Chondrosarcoma Lung Metastasis cell lines, lung .a 1913 to 2584 1 to 666       666/831
(80 %)
12 diff
(98.6 %id)
AW579424 denis_drash .a 1929 to 2276 16 to 362       347/362
(95 %)
7 diff
(98.1 %id)
BF882974 lung_tumor .a 1929 to 2421 1 to 493       493/493
(100 %)
0 diff
(100 %id)
DA596219   .a 1948 to 2495 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA453182 tongue, tumor tissue .a 1962 to 2534 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BQ368361 placenta_normal .a 1963 to 2353 12 to 402       391/402
(97 %)
9 diff
(97.8 %id)
BQ368369 placenta_normal .a 1963 to 2241 27 to 303       277/303
(91 %)
6 diff
(98.1 %id)
BQ368352 placenta_normal .a 1964 to 2160 3 to 196       194/208
(93 %)
8 diff
(96.2 %id)
CF137387 lymph .a 1972 to 2122 8 to 158       151/158
(95 %)
6 diff
(96.3 %id)
CR591731 Placenta Cot 25-normalized .a 1973 to 2954 1 to 982       982/982
(100 %)
0 diff
(100 %id)
BX361139 Placenta Cot 25-normalized .a 1973 to 2942 1 to 961   fully sequenced,   961/961
(100 %)
11 diff
(98.9 %id)
BE927741 colon .a 1980 to 2328 351 to 3       349/375
(93 %)
1 diff
(99.8 %id)
BQ068789 brain, neuroblastoma, cell line .a 2009 to 2876 24 to 894       871/994
(87 %)
14 diff
(98.6 %id)
BF846238 lung_normal .a 2014 to 2277 1 to 262       262/265
(98 %)
4 diff
(98.5 %id)
CN279239 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2016 to 2803 1 to 790       790/790
(100 %)
5 diff
(99.4 %id)
BI334481 cervical carcinoma cell line, cervix .a 2018 to 2090 1 to 72       72/72
(100 %)
2 diff
(97.3 %id)
BE927761 colon .a 2029 to 2334 1 to 307       307/324
(94 %)
19 diff
(94.2 %id)
BI043238 ovary .a 2039 to 2515 17 to 491       475/498
(95 %)
11 diff
(97.8 %id)
CN279223 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2050 to 2611 1 to 562       562/562
(100 %)
0 diff
(100 %id)
CN279234 embryonic stem cells, cell lines H1, H7, andH9 .a 2152 to 2839 15 to 702       688/702
(98 %)
0 diff
(100 %id)
BP220828 colon .a 2173 to 2743 1 to 571       571/571
(100 %)
4 diff
(99.3 %id)
AL121552 melanoma (MeWo cell line) .a 2188 to 2614 1 to 427       427/427
(100 %)
2 diff
(99.6 %id)
CN279233 embryonic stem cells, DMSO-treated H9 cellline .a 2190 to 2913 1 to 724       724/724
(100 %)
4 diff
(99.5 %id)
DA778796 brain .a 2207 to 2781 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BU159509 eye, retinoblastoma .a 2210 to 3057 1 to 853       853/876
(97 %)
15 diff
(98.3 %id)
CO249481 Chondrosarcoma Lung Metastasis cell lines, lung .a 2212 to 2970 7 to 764       758/764
(99 %)
5 diff
(99.4 %id)
DB160776 thymus .a 2218 to 2799 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
BM449841 melanotic melanoma, skin .a 2243 to 2876 1 to 636       636/917
(69 %)
19 diff
(98.0 %id)
DB133256 thymus .a 2247 to 2707 2 to 462   capped   461/461
(100 %)
1 diff
(99.8 %id)
BX370767   .a 2285 to 3158 20 to 893       874/893
(97 %)
8 diff
(99.2 %id)
BM764763 Ascites, stomach .a 2305 to 2984 1 to 681       681/681
(100 %)
1 diff
(99.9 %id)
BF857434 prostate_tumor .a 2313 to 2795 484 to 1     Submitted on the opposite strand 484/484
(100 %)
3 diff
(99.4 %id)
BI333776 cervical carcinoma cell line, cervix .a 2317 to 3012 1 to 696       696/696
(100 %)
1 diff
(99.9 %id)
BI334974 cervical carcinoma cell line, cervix .a 2328 to 3154 10 to 840       831/844
(98 %)
23 diff
(97.3 %id)
CN279242 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2331 to 2667 337 to 1     Submitted on the opposite strand 337/337
(100 %)
0 diff
(100 %id)
BX361138 Placenta Cot 25-normalized .a 2345 to 2952 610 to 1   fully sequenced,   610/610
(100 %)
10 diff
(98.4 %id)
BU159622 eye, retinoblastoma .a 2352 to 3167 1 to 818       818/837
(97 %)
6 diff
(99.3 %id)
DA739116   .a 2367 to 2854 2 to 489   capped   488/488
(100 %)
2 diff
(99.6 %id)
CX754240 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2375 to 3095 721 to 1       721/785
(91 %)
1 diff
(99.9 %id)
DA619114   .a 2384 to 2926 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
AW957585   .a 2420 to 2928 517 to 9     Submitted on the opposite strand 509/517
(98 %)
4 diff
(99.3 %id)
DA595989   .a 2422 to 3113 2 to 693   capped   692/696
(99 %)
1 diff
(99.9 %id)
DA647977   .a 2444 to 2987 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
BE797142 lung, small cell carcinoma .a 2448 to 3176 1 to 739       739/925
(79 %)
19 diff
(98.0 %id)
BE541904 cervix .a 2478 to 3184 1 to 701       703/729
(96 %)
30 diff
(95.9 %id)
CN279226 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2482 to 3227 1 to 746       746/746
(100 %)
1 diff
(99.9 %id)
CO400828 Chondrosarcoma Lung Metastasis cell lines, lung .a 2482 to 3171 1 to 688       688/863
(79 %)
9 diff
(99.0 %id)
BE734696 choriocarcinoma, placenta .a 2489 to 3166 7 to 690       684/932
(73 %)
12 diff
(98.8 %id)
BE409852 choriocarcinoma, placenta .a 2511 to 3171 26 to 695       670/893
(75 %)
17 diff
(98.1 %id)
DA039137 bladder .a 2531 to 3068 2 to 538   capped   537/537
(100 %)
4 diff
(99.3 %id)
AL135137 melanoma (MeWo cell line) .a 2542 to 3313 1 to 772       772/772
(100 %)
0 diff
(100 %id)
BQ949827 sciatic nerve .a 2544 to 3282 29 to 766       738/981
(75 %)
13 diff
(98.7 %id)
BE873284 adenocarcinoma, colon .a 2552 to 3171 1 to 625       625/996
(62 %)
15 diff
(98.5 %id)
BM829097 Ascites, stomach .a 2558 to 2720 1 to 163       163/163
(100 %)
2 diff
(98.8 %id)
BE882339 leiomyosarcoma, uterus .a 2578 to 3152 1 to 575       575/575
(100 %)
0 diff
(100 %id)
DA697831   .a 2579 to 3154 2 to 578   capped   577/578
(99 %)
2 diff
(99.7 %id)
BF816586 colon_ins .a 2583 to 2755 171 to 1     Submitted on the opposite strand 171/171
(100 %)
4 diff
(97.7 %id)
AA350853 brain .a 2589 to 2926 339 to 1     Submitted on the opposite strand 339/339
(100 %)
1 diff
(99.8 %id)
AU139196 placenta .a 2601 to 3311 2 to 715   capped   714/716
(99 %)
5 diff
(99.4 %id)
BQ335621 marrow .a 2602 to 2856 19 to 273       255/273
(93 %)
5 diff
(98.2 %id)
TI_1968233421   .a 2643 to 3764 1128 to 10       1119/1295
(86 %)
6 diff
(99.6 %id)
DA436993 tongue, tumor tissue .a 2645 to 3221 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
CN279230 embryonic stem cells, cell lines H1, H7, andH9 .a 2681 to 3204 8 to 531       524/531
(98 %)
2 diff
(99.7 %id)
BF816474 colon_ins .a 2703 to 2989 316 to 27     Submitted on the opposite strand 292/335
(87 %)
4 diff
(98.9 %id)
CX785624 human embryonic stem cells .a 2703 to 3498 15 to 810       796/810
(98 %)
6 diff
(99.3 %id)
BG388346 embryonal carcinoma, cell line, testis .a 2704 to 3476 1 to 767       767/772
(99 %)
18 diff
(97.7 %id)
BP303959   .a 2704 to 3279 1 to 574       574/582
(98 %)
21 diff
(96.4 %id)
BE280713 choriocarcinoma, placenta .a 2707 to 3155 1 to 449       449/718
(62 %)
7 diff
(99.1 %id)
AI291623 carcinoid, lung .a 2721 to 3201 1 to 481     Submitted on the opposite strand 481/481
(100 %)
1 diff
(99.8 %id)
BQ344948 nervous_tumor .a 2733 to 3102 374 to 1       350/374
(93 %)
18 diff
(95.2 %id)
BE504271 carcinoid, lung .a 2744 to 3279 1 to 536     Submitted on the opposite strand 536/536
(100 %)
0 diff
(100 %id)
AI292103 carcinoid, lung .a 2745 to 3212 1 to 468     Submitted on the opposite strand 468/469
(99 %)
2 diff
(99.6 %id)
AU135653 placenta .a 2777 to 3400 2 to 630   capped   629/649
(96 %)
14 diff
(97.9 %id)
DA962009 Spleen .a 2778 to 3327 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CN279240 embryonic stem cells, cell lines H1, H7, andH9 .a 2795 to 3274 1 to 480       480/480
(100 %)
3 diff
(99.4 %id)
CA396119 eye, RPE/choroid .a 2799 to 3336 1 to 538       538/538
(100 %)
2 diff
(99.7 %id)
DA838938 placenta .a 2799 to 3351 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA477526   .a 2801 to 3379 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
CA390160 eye, RPE/choroid .a 2810 to 3397 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BF738951 bladder_tumor .a 2812 to 3029 240 to 18     Submitted on the opposite strand 223/256
(87 %)
14 diff
(94.6 %id)
BI856801 breast, mammary adenocarcinoma, cell line .a 2818 to 3400 1 to 583       583/583
(100 %)
6 diff
(99.0 %id)
TI_57190478   .a 2818 to 3400 52 to 634       583/583
(100 %)
6 diff
(99.0 %id)
TI_154152927   .a 2821 to 3399 658 to 80     Submitted on the opposite strand 579/579
(100 %)
7 diff
(98.8 %id)
DA865726 Prostate .a 2836 to 3398 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BG013653 placenta_normal .a 2853 to 3326 21 to 496       476/497
(95 %)
22 diff
(95.6 %id)
BU431127 lymph .a 2904 to 3399 503 to 8     Submitted on the opposite strand 496/503
(98 %)
3 diff
(99.5 %id)
BM561769 duodenal adenocarcinoma, cell line, small intestine .a 2911 to 3905 1 to 1009       1009/1011
(99 %)
25 diff
(97.6 %id)
CF135956 lymph .a 2920 to 3107 1 to 188       188/188
(100 %)
2 diff
(99.0 %id)
BF913896 uterus_tumor .a 2928 to 3253 340 to 16     Submitted on the opposite strand 325/357
(91 %)
4 diff
(98.9 %id)
DB117719 thymus .a 2930 to 3282 2 to 354   capped   353/353
(100 %)
0 diff
(100 %id)
DA439513 tongue, tumor tissue .a 2931 to 3499 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BG477989 melanotic melanoma, skin .a 2931 to 3482 1 to 548       548/557
(98 %)
7 diff
(98.8 %id)
BF027405 melanotic melanoma, skin .a 2935 to 3600 45 to 708       664/1039
(63 %)
18 diff
(98.3 %id)
AW890339 nervous_tumor .a 2943 to 3170 238 to 11       234/246
(95 %)
2 diff
(99.2 %id)
BF798749 colon_ins .a 2946 to 3078 163 to 33     Submitted on the opposite strand 131/163
(80 %)
2 diff
(98.8 %id)
BE408764 choriocarcinoma, placenta .a 2951 to 3596 1 to 644       646/670
(96 %)
19 diff
(97.2 %id)
BF026544 melanotic melanoma, skin .a 2951 to 3499 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
BM849263 myeloma .a 2963 to 3515 1 to 553       553/553
(100 %)
0 diff
(100 %id)
CF131915 Chondrosarcoma Lung Metastasis cell lines, lung .a 2964 to 3662 1 to 701       701/701
(100 %)
2 diff
(99.8 %id)
TI_159677619   .a 2964 to 3862 51 to 943       893/1053
(84 %)
16 diff
(98.5 %id)
EC528025 Prostate .a 2967 to 3051 100 to 16       85/100
(85 %)
0 diff
(100 %id)
BG008551 placenta_normal .a 2979 to 3247 280 to 14       267/283
(94 %)
0 diff
(100 %id)
DA766807 tongue .a 3020 to 3586 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BQ073075 leukocyte .a 3023 to 3910 25 to 919       895/1097
(81 %)
26 diff
(97.7 %id)
DA701507   .a 3023 to 3541 2 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
BF568523 epithelioid carcinoma cell line, Pancreas .a 3025 to 3642 1 to 615       616/618
(99 %)
10 diff
(98.4 %id)
BF568689 epithelioid carcinoma cell line, Pancreas .a 3025 to 3665 1 to 635       636/737
(86 %)
20 diff
(97.3 %id)
BG831931 epithelioid carcinoma cell line, Pancreas .a 3025 to 3657 1 to 635       635/635
(100 %)
6 diff
(99.1 %id)
BI457153 epithelioid carcinoma cell line, Pancreas .a 3025 to 3686 1 to 666       667/740
(90 %)
32 diff
(95.7 %id)
DA689331   .a 3025 to 3571 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
TI_45133393   .a 3026 to 3686 63 to 727       666/739
(90 %)
31 diff
(95.9 %id)
DA619830   .a 3044 to 3623 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CN279220 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3053 to 3711 1 to 658       658/658
(100 %)
1 diff
(99.9 %id)
AW631421 2 pooled high-grade transitional celltumors, genitourinary tract .a 3062 to 3457 1 to 395       395/395
(100 %)
4 diff
(99.0 %id)
CX760953 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 3103 to 3821 1 to 710     Submitted on the opposite strand 710/835
(85 %)
15 diff
(98.3 %id)
BP203167 coronary artery .a 3105 to 3650 2 to 548       547/550
(99 %)
9 diff
(98.4 %id)
BQ932021 eye, normal pigmented retinal epithelium .a 3120 to 3997 1 to 894       894/911
(98 %)
24 diff
(97.4 %id)
DA822981 pericardium .a 3141 to 3701 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA671630   .a 3146 to 3726 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DB210262 trachea .a 3164 to 3759 2 to 599   capped   598/599
(99 %)
4 diff
(99.4 %id)
BG106517 lymph, lymphoma, cell line .a 3174 to 3932 1 to 744       744/949
(78 %)
16 diff
(98.4 %id)
BE872952 adenocarcinoma, colon .a 3182 to 3709 1 to 522       522/522
(100 %)
7 diff
(98.7 %id)
CN279244 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3228 to 3640 13 to 426       414/426
(97 %)
7 diff
(98.4 %id)
AU118269 whole embryo, mainly head .a 3237 to 4019 2 to 778   capped   777/817
(95 %)
16 diff
(98.1 %id)
BU431128 lymph .a 3242 to 3399 165 to 8     Submitted on the opposite strand 157/165
(95 %)
7 diff
(95.8 %id)
CR996897 T-Lymphocytes .a 3253 to 3579 1 to 328       328/330
(99 %)
3 diff
(99.1 %id)
BF797166 lymph, lymphoma, cell line .a 3254 to 3976 1 to 719       719/968
(74 %)
25 diff
(97.5 %id)
BQ953040 epidermoid carcinoma, cell line, lung .a 3260 to 4134 1 to 877       877/890
(98 %)
2 diff
(99.8 %id)
DA421635 cervix .a 3277 to 3842 2 to 568   capped   567/567
(100 %)
4 diff
(99.3 %id)
DA432620 colon .a 3294 to 3837 2 to 545   capped   544/544
(100 %)
5 diff
(99.1 %id)
BG256742 embryonal carcinoma, cell line, testis .a 3311 to 3825 1 to 517       517/519
(99 %)
16 diff
(97.0 %id)
AL047438 uterus .a 3321 to 3899 1 to 580       580/583
(99 %)
2 diff
(99.7 %id)
CN279221 embryonic stem cells, cell lines H1, H7, andH9 .a 3322 to 4015 1 to 694       694/694
(100 %)
1 diff
(99.9 %id)
BM194526 leukopheresis .a 3334 to 3868 535 to 1       535/535
(100 %)
5 diff
(99.1 %id)
BF664450 B-cells, primary B-cells from tonsils (cell line) .a 3343 to 3882 1 to 538       539/538
(100 %)
7 diff
(98.7 %id)
BG755006 B-cells, primary B-cells from tonsils (cell line) .a 3343 to 4098 1 to 744       744/746
(99 %)
21 diff
(97.2 %id)
DA033758   .a 3345 to 3918 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
CD300123 testis .a 3357 to 4159 1 to 822       822/874
(94 %)
23 diff
(97.4 %id)
CD300281 testis .a 3358 to 4190 31 to 872       842/886
(95 %)
18 diff
(98.0 %id)
AU134869 placenta .a 3361 to 3978 2 to 625   capped   624/629
(99 %)
15 diff
(97.7 %id)
DA057969 cerebellum .a 3375 to 3933 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BF204552 muscle, rhabdomyosarcoma .a 3380 to 4114 1 to 728       728/1136
(64 %)
37 diff
(96.8 %id)
CR744688 B-cell, chronic lymphotic leukemia .a 3381 to 3836 1 to 456       456/456
(100 %)
0 diff
(100 %id)
BG480494 choriocarcinoma, placenta .a 3392 to 3972 1 to 580       580/580
(100 %)
9 diff
(98.5 %id)
BE294885 muscle, rhabdomyosarcoma .a 3401 to 4084 1 to 679       679/700
(97 %)
31 diff
(95.6 %id)
BE407355 choriocarcinoma, placenta .a 3413 to 3969 1 to 558       558/558
(100 %)
10 diff
(98.3 %id)
BE731527 choriocarcinoma, placenta .a 3413 to 4216 1 to 811       811/1109
(73 %)
50 diff
(95.5 %id)
CN279225 embryonic stem cells, DMSO-treated H9 cellline .a 3422 to 3880 1 to 456       456/456
(100 %)
1 diff
(99.8 %id)
BE782423 eye, retinoblastoma .a 3433 to 4131 1 to 691       691/692
(99 %)
25 diff
(96.4 %id)
BQ022258 placenta .a 3439 to 3677 270 to 31   AAA   244/253
(96 %)
0 diff
(100 %id)
BM546778 ovary (pool of 3) .a 3452 to 4295 21 to 877       857/1094
(78 %)
30 diff
(97.3 %id)
BQ927369 large cell carcinoma, lung .a 3452 to 4213 24 to 788       765/970
(78 %)
17 diff
(98.3 %id)
BE791111 lung, small cell carcinoma .a 3484 to 4197 1 to 714       714/1164
(61 %)
21 diff
(98.2 %id)
AW631359 2 pooled high-grade transitional celltumors, genitourinary tract .a 3499 to 4031 1 to 533       533/534
(99 %)
10 diff
(98.2 %id)
TI_57202710   .a 3515 to 4178 67 to 726       660/726
(90 %)
19 diff
(97.4 %id)
BI823530 pooled brain, lung, testis .a 3516 to 4178 1 to 660       660/660
(100 %)
16 diff
(97.6 %id)
BP266089 thyroid .a 3519 to 4097 1 to 579       579/579
(100 %)
0 diff
(100 %id)
AL544677 placenta, Placenta Cot 25-normalized .a 3529 to 4302 34 to 807   fully sequenced,   774/807
(95 %)
19 diff
(97.7 %id)
TI_1968231231   .a 3538 to 4496 1020 to 58       963/1033
(93 %)
15 diff
(98.6 %id)
BX329340   .a 3538 to 4436 892 to 1       892/895
(99 %)
19 diff
(97.9 %id)
CF242811 Brain glioblastoma .a 3603 to 4438 1 to 844       844/879
(96 %)
17 diff
(98.1 %id)
BG925029 cartilage .a 3613 to 3942 83 to 414       332/350
(94 %)
5 diff
(98.6 %id)
BE795790 lung, small cell carcinoma .a 3625 to 4407 27 to 815       787/919
(85 %)
28 diff
(97.0 %id)
CV311480 head_neck .a 3646 to 3968 71 to 397       327/398
(82 %)
30 diff
(92.5 %id)
BQ072157 brain, neuroblastoma, cell line .a 3649 to 4528 1 to 885       885/1056
(83 %)
24 diff
(97.8 %id)
BQ068450 brain, neuroblastoma, cell line .a 3650 to 4464 26 to 848       823/1029
(79 %)
19 diff
(98.2 %id)
CX164169 human embryonic stem cells differentiated toan early endodermal cell type .a 3659 to 4391 1 to 733       733/733
(100 %)
0 diff
(100 %id)
BG477581 melanotic melanoma, skin .a 3684 to 4411 1 to 742       738/743
(99 %)
34 diff
(95.5 %id)
BF761210 colon_est .a 3754 to 4127 376 to 1     Submitted on the opposite strand 376/376
(100 %)
6 diff
(98.5 %id)
CN279241 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3767 to 4174 409 to 2     Submitted on the opposite strand 408/409
(99 %)
0 diff
(100 %id)
BF761209 colon_est .a 3781 to 4176 394 to 1     Submitted on the opposite strand 394/394
(100 %)
10 diff
(97.5 %id)
BQ922507 epidermoid carcinoma, cell line, lung .a 3801 to 4706 1 to 916       916/950
(96 %)
29 diff
(97.0 %id)
BM051290 eye, normal pigmented retinal epithelium .a 3805 to 4575 1 to 778       778/778
(100 %)
22 diff
(97.2 %id)
TI_149290425   .a 3819 to 4534 776 to 62   AAA   715/795
(89 %)
56 diff
(93.0 %id)
BF206858 brain, neuroblastoma .a 3836 to 4564 1 to 718       718/866
(82 %)
39 diff
(95.5 %id)
BF207234 brain, neuroblastoma .a 3836 to 4395 1 to 556       556/556
(100 %)
8 diff
(98.6 %id)
BI194873 brain, neuroblastoma .a 3836 to 4531 1 to 692       692/692
(100 %)
7 diff
(99.0 %id)
BF314576 brain, neuroblastoma .a 3870 to 4589 1 to 703       703/920
(76 %)
18 diff
(98.1 %id)
T08115   .a 3872 to 4223 1 to 353       353/356
(99 %)
12 diff
(96.7 %id)
BM769439 stomach .a 3874 to 4478 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BM769691 stomach .a 3874 to 4469 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BI116683 lung, small cell carcinoma .a 3914 to 4525 1 to 613       613/614
(99 %)
8 diff
(98.7 %id)
BM852342 Ascites, stomach .a 3916 to 4183 1 to 265       265/265
(100 %)
15 diff
(94.4 %id)
L24444   .a 3942 to 5192 15 to 1266       1252/1269
(98 %)
7 diff
(99.5 %id)
BQ073207 epidermoid carcinoma, cell line, lung .a 3985 to 4759 1 to 783       783/963
(81 %)
19 diff
(98.1 %id)
BF761201 colon_est .a 3993 to 4166 183 to 5     Submitted on the opposite strand 179/183
(97 %)
0 diff
(100 %id)
CN485002 eye .a 4002 to 4628 1 to 627       627/627
(100 %)
0 diff
(100 %id)
BG674286 skin .a 4004 to 4616 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
BF530073 anaplastic oligodendroglioma with 1p/19qloss, brain .a 4024 to 4668 1 to 645       645/646
(99 %)
1 diff
(99.9 %id)
TI_57190363   .a 4035 to 4824 52 to 860       807/836
(96 %)
41 diff
(95.1 %id)
BI856397 breast, mammary adenocarcinoma, cell line .a 4036 to 4824 1 to 808       806/835
(96 %)
40 diff
(95.3 %id)
CN279228 embryonic stem cells, DMSO-treated H9 cellline .a 4049 to 4672 1 to 626       626/626
(100 %)
2 diff
(99.7 %id)
BP316707 pericardium .a 4067 to 4649 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BM973423 lung .a 4080 to 4534 474 to 19   AAA   456/456
(100 %)
3 diff
(99.4 %id)
BI091114 cervix .a 4085 to 4798 1 to 703       703/822
(85 %)
20 diff
(97.6 %id)
CT004069 T-Lymphocytes .a 4087 to 4742 7 to 669       663/676
(98 %)
8 diff
(98.9 %id)
AL582754 B cells from Burkitt lymphoma .a 4089 to 4973 885 to 1       885/988
(89 %)
28 diff
(97.2 %id)
BX418521 brain, fetal brain .a 4116 to 5176 1052 to 1       1052/1070
(98 %)
19 diff
(98.3 %id)
BG394812 eye, retinoblastoma .a 4116 to 4405 308 to 19   available from MGC, Submitted on the opposite strand 290/545
(53 %)
0 diff
(100 %id)
BG475929 melanotic melanoma, skin .a 4116 to 4778 1 to 675       675/856
(78 %)
27 diff
(96.9 %id)
BU191621 epidermoid carcinoma, cell line, salivary gland .a 4128 to 4755 31 to 660       630/981
(64 %)
18 diff
(98.2 %id)
BQ952193 sciatic nerve .a 4134 to 4905 1 to 774       774/911
(84 %)
24 diff
(97.4 %id)
TI_149293630   .a 4147 to 5024 957 to 87   AAA   871/1002
(86 %)
16 diff
(98.5 %id)
AA179030 muscle, skeletal muscle .a 4190 to 4565 1 to 373   fully sequenced,   373/373
(100 %)
3 diff
(99.2 %id)
CN279238 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4205 to 4725 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BQ925706 sciatic nerve .a 4210 to 5012 1 to 818       818/953
(85 %)
25 diff
(97.4 %id)
BE798349 lung, small cell carcinoma .a 4220 to 5068 9 to 850       842/982
(85 %)
38 diff
(96.2 %id)
TI_149297960   .a 4225 to 5025 884 to 85   AAA   800/972
(82 %)
12 diff
(98.8 %id)
BI015891 lung_tumor .a 4238 to 4707 473 to 4       470/482
(97 %)
2 diff
(99.6 %id)
BU529110 epidermoid carcinoma, cell line, lung .a 4246 to 5024 821 to 36     Submitted on the opposite strand 786/831
(94 %)
14 diff
(98.4 %id)
BE797303 lung, small cell carcinoma .a 4252 to 4951 1 to 700       700/701
(99 %)
3 diff
(99.6 %id)
BM467367 duodenal adenocarcinoma, cell line, small intestine .a 4258 to 4884 1 to 627       627/1164
(53 %)
10 diff
(99.2 %id)
BU682750 lung .a 4264 to 5024 774 to 19   AAA   756/756
(100 %)
4 diff
(99.5 %id)
EC480001 Prostate .a 4271 to 4366 95 to 1       95/95
(100 %)
2 diff
(97.9 %id)
EC509028 Prostate .a 4271 to 4366 96 to 1       96/96
(100 %)
1 diff
(99.0 %id)
AL570723 placenta, Placenta Cot 25-normalized .a 4275 to 5152 877 to 1   fully sequenced,   877/877
(100 %)
59 diff
(93.3 %id)
CD367913 Alveolar Macrophage, lung .a 4285 to 5020 754 to 19   AAA   736/736
(100 %)
2 diff
(99.8 %id)
BE313364 brain, neuroblastoma .a 4289 to 4491 1 to 203       203/203
(100 %)
0 diff
(100 %id)
BE796806 lung, small cell carcinoma .a 4289 to 4675 1 to 384       384/418
(91 %)
18 diff
(95.7 %id)
CA426719 cell lines, Chondrosarcoma .a 4289 to 5020 751 to 19   AAA   733/735
(99 %)
2 diff
(99.8 %id)
BX412648 brain, fetal brain .a 4295 to 5184 892 to 7       886/892
(99 %)
11 diff
(98.8 %id)
BM692261 eye, human retina .a 4299 to 4809 1 to 510       510/510
(100 %)
14 diff
(97.3 %id)
BM982865 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 4331 to 5025 713 to 19   AAA   695/695
(100 %)
3 diff
(99.6 %id)
BE745387 adenocarcinoma cell line, ovary .a 4336 to 5169 1 to 829       829/850
(97 %)
25 diff
(97.1 %id)
CA305889 Alveolar Macrophage, lung .a 4338 to 5024 705 to 19   AAA   687/687
(100 %)
0 diff
(100 %id)
TI_151759594   .a 4363 to 5191 911 to 85   AAA   827/968
(85 %)
11 diff
(98.9 %id)
BF808333 colon_ins .a 4366 to 4630 1 to 267       267/267
(100 %)
3 diff
(98.9 %id)
BG252681 adenocarcinoma, cell line, Liver .a 4369 to 5105 1 to 726       726/917
(79 %)
18 diff
(98.1 %id)
BM508968 insulinoma, Pancreas .a 4372 to 4844 1 to 473       473/473
(100 %)
6 diff
(98.8 %id)
BI710921 insulinoma, Pancreas .a 4372 to 4812 1 to 441   fully sequenced,   441/441
(100 %)
6 diff
(98.7 %id)
BM511058 insulinoma, Pancreas .a 4372 to 4922 1 to 551   fully sequenced,   551/551
(100 %)
6 diff
(99.0 %id)
BM511366 insulinoma, Pancreas .a 4372 to 4816 1 to 445   fully sequenced,   445/445
(100 %)
6 diff
(98.7 %id)
BQ549001 insulinoma, Pancreas .a 4372 to 4809 1 to 438   fully sequenced,   438/438
(100 %)
6 diff
(98.7 %id)
BQ614477 insulinoma, Pancreas .a 4372 to 4818 1 to 447   fully sequenced,   447/447
(100 %)
6 diff
(98.7 %id)
BQ787328.
matches multiple genes
insulinoma, Pancreas .a 4372 to 4519 1 to 147     also hits gene PRSS3 147/147
(100 %)
11 diff
(92.6 %id)
BQ787351 insulinoma, Pancreas .a 4372 to 4817 1 to 446   fully sequenced,   446/446
(100 %)
6 diff
(98.7 %id)
BQ787357 insulinoma, Pancreas .a 4372 to 4821 1 to 450   fully sequenced,   450/450
(100 %)
6 diff
(98.7 %id)
TI_149299342   .a 4374 to 5198 873 to 67   AAA   807/809
(99 %)
47 diff
(94.2 %id)
BF855494 prostate_normal .a 4380 to 4651 7 to 277       271/289
(93 %)
17 diff
(94.2 %id)
EC474690 Prostate .a 4382 to 4476 1 to 95       95/95
(100 %)
0 diff
(100 %id)
BF855962 prostate_normal .a 4385 to 4479 9 to 105       97/114
(85 %)
5 diff
(95.7 %id)
AA044624 uterus .a 4393 to 4792 1 to 386   fully sequenced,   386/386
(100 %)
0 diff
(100 %id)
AA149170 uterus .a 4394 to 4838 1 to 448       448/449
(99 %)
10 diff
(97.8 %id)
BE798007 lung, small cell carcinoma .a 4398 to 5184 43 to 829       787/846
(93 %)
16 diff
(98.2 %id)
BE798116 lung, small cell carcinoma .a 4406 to 5191 48 to 835       788/886
(88 %)
26 diff
(97.1 %id)
CR989694 T-Lymphocytes .a 4439 to 4882 1 to 446   AAA   446/446
(100 %)
9 diff
(98.0 %id)
T98550 liver and spleen .a 4449 to 4815 1 to 382       382/389
(98 %)
16 diff
(95.9 %id)
BM711421 eye, fetal eyes .a 4455 to 4896 1 to 442   fully sequenced,   442/442
(100 %)
0 diff
(100 %id)
AW581049 leiomios .a 4465 to 4789 19 to 339       321/339
(94 %)
6 diff
(98.3 %id)
BP223925 colon mucosa .a 4465 to 4899 1 to 435       435/435
(100 %)
4 diff
(99.1 %id)
AW581044 leiomios .a 4487 to 4789 1 to 303       303/303
(100 %)
5 diff
(98.4 %id)
CD612036   .a 4496 to 4597 1 to 103       103/115
(89 %)
9 diff
(92.2 %id)
BF063347 colon, colon tumor, RER+ .a 4499 to 5020 532 to 11   AAA   522/522
(100 %)
0 diff
(100 %id)
CA309644 Alveolar Macrophage, lung .a 4502 to 5191 708 to 19   AAA   690/690
(100 %)
2 diff
(99.8 %id)
CA314841 Human Lung Epithelial cells, lung .a 4505 to 5191 705 to 19   AAA   687/687
(100 %)
2 diff
(99.8 %id)
AW015515   .a 4507 to 5024 535 to 18   AAA   518/518
(100 %)
1 diff
(99.9 %id)
T27903 eye .a 4519 to 4831 1 to 314       314/314
(100 %)
1 diff
(99.7 %id)
CD368993 Alveolar Macrophage, lung .a 4525 to 5191 685 to 19   AAA   667/667
(100 %)
2 diff
(99.8 %id)
BU632042 cell lines, Chondrosarcoma .a 4527 to 5191 683 to 19   AAA   665/665
(100 %)
1 diff
(99.9 %id)
TI_149285561   .a 4531 to 5220 751 to 63       689/782
(88 %)
0 diff
(100 %id)
BM971478 lung .a 4531 to 5198 685 to 19   AAA   667/677
(98 %)
6 diff
(99.2 %id)
BE790734 lung, small cell carcinoma .a 4532 to 5185 1 to 658       658/658
(100 %)
17 diff
(97.5 %id)
BM707346 eye, eye anterior segment .a 4532 to 4974 8 to 450       443/450
(98 %)
6 diff
(98.7 %id)
AA178938 muscle, skeletal muscle .a 4535 to 5024 487 to 1   fully sequenced,   487/487
(100 %)
13 diff
(97.4 %id)
AA026228 uterus .a 4545 to 4730 1 to 185       185/188
(98 %)
10 diff
(94.7 %id)
R69917 placenta .a 4557 to 4859 13 to 312   fully sequenced,   300/312
(96 %)
6 diff
(98.1 %id)
N39795 placenta .a 4567 to 4786 1 to 217       217/217
(100 %)
3 diff
(98.7 %id)
DB532937 hippocampus .a 4569 to 5229 1 to 668     Submitted on the opposite strand 668/668
(100 %)
27 diff
(96.0 %id)
AI311654 2 pooled tumors (clear cell type), Kidney .a 4570 to 5024 458 to 4       455/458
(99 %)
0 diff
(100 %id)
BQ013194 placenta .a 4582 to 5020 457 to 19   AAA   439/439
(100 %)
0 diff
(100 %id)
CA312083 Human Lung Epithelial cells, lung .a 4582 to 5195 632 to 19   AAA   614/614
(100 %)
0 diff
(100 %id)
BQ013560 placenta .a 4589 to 5212 624 to 1       624/624
(100 %)
6 diff
(99.1 %id)
AI523874 B-cell, chronic lymphotic leukemia .a 4591 to 5021 432 to 2       431/432
(99 %)
0 diff
(100 %id)
BU626253 cell lines, Enchondroma .a 4593 to 5191 617 to 19   AAA   599/599
(100 %)
0 diff
(100 %id)
AU144871 whole embryo, mainly head .a 4599 to 5198 601 to 1       601/601
(100 %)
11 diff
(98.2 %id)
BG494546 lung, mucoepidermoid carcinoma .a 4600 to 5181 1 to 579       579/698
(82 %)
23 diff
(96.8 %id)
AW167387 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4602 to 5021 420 to 1       420/420
(100 %)
1 diff
(99.8 %id)
BF342191 brain, glioblastoma with EGFR amplification .a 4622 to 5196 24 to 600       577/648
(89 %)
3 diff
(99.6 %id)
BF663371 B-cells, primary B-cells from tonsils (cell line) .a 4626 to 5191 1 to 567       567/1135
(49 %)
2 diff
(99.9 %id)
BM505605 insulinoma, Pancreas .a 4628 to 5197 588 to 18   AAA   571/571
(100 %)
2 diff
(99.7 %id)
BE501793 Kidney .a 4637 to 5191 555 to 1       555/555
(100 %)
1 diff
(99.9 %id)
AW044313 thymus, pooled .a 4638 to 5191 554 to 1       554/554
(100 %)
0 diff
(100 %id)
BU754009 placenta .a 4638 to 5020 400 to 18   AAA   383/383
(100 %)
0 diff
(100 %id)
AI423000 brain, glioblastoma (pooled) .a 4639 to 5024 395 to 10       386/395
(97 %)
0 diff
(100 %id)
AI393907 B-cell, chronic lymphotic leukemia .a 4639 to 5020 392 to 11   AAA   382/382
(100 %)
0 diff
(100 %id)
AI160623 placenta .a 4657 to 5021 371 to 7       365/371
(98 %)
0 diff
(100 %id)
AI760624 colon, colon tumor, RER+ .a 4658 to 5190 533 to 1       533/533
(100 %)
1 diff
(99.9 %id)
BQ187539 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4667 to 5020 1 to 354   AAA   354/354
(100 %)
2 diff
(99.5 %id)
BQ574797 Chondrosarcoma Grade II, Left Pelvis .a 4667 to 5190 542 to 19   AAA   524/533
(98 %)
0 diff
(100 %id)
BE549565 carcinoid, lung .a 4668 to 5192 532 to 8       525/532
(98 %)
0 diff
(100 %id)
CA444995 lung, Metastatic Chondrosarcoma .a 4687 to 5191 523 to 19   AAA   505/505
(100 %)
0 diff
(100 %id)
AI623104 Prostate .a 4692 to 5021 333 to 4       330/333
(99 %)
0 diff
(100 %id)
BE223103 brain, oligodendroglioma .a 4692 to 5191 500 to 1       500/500
(100 %)
0 diff
(100 %id)
BM986916 mixed .a 4699 to 5020 340 to 19   AAA   322/322
(100 %)
4 diff
(98.8 %id)
AW008039 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4703 to 5020 353 to 35   AAA   319/319
(100 %)
22 diff
(93.2 %id)
BI334489 cervical carcinoma cell line, cervix .a 4703 to 5192 1 to 489       489/780
(62 %)
2 diff
(99.8 %id)
AI692411 carcinoid, lung .a 4704 to 5024 352 to 32   AAA   321/321
(100 %)
17 diff
(94.8 %id)
AU155284 ovary, tumor tissue .a 4720 to 5190 471 to 1       471/472
(99 %)
11 diff
(97.7 %id)
AW469115 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4723 to 5200 478 to 1       478/478
(100 %)
1 diff
(99.8 %id)
AW270841 Kidney .a 4724 to 5192 471 to 3       469/471
(99 %)
0 diff
(100 %id)
BG057357 blood, lymphocyte .a 4724 to 5191 482 to 15   AAA   468/468
(100 %)
2 diff
(99.6 %id)
BE045446 carcinoid, lung .a 4725 to 5202 480 to 3       478/480
(99 %)
0 diff
(100 %id)
AW770091 pooled .a 4725 to 5190 466 to 1       466/466
(100 %)
2 diff
(99.6 %id)
AI984978 Kidney .a 4726 to 5191 465 to 1       465/465
(100 %)
1 diff
(99.8 %id)
BM664483 eye, human retina .a 4726 to 5191 485 to 19   AAA   467/467
(100 %)
8 diff
(98.3 %id)
AI075886   .a 4728 to 5192 470 to 6       465/470
(98 %)
0 diff
(100 %id)
BE350880 malignant melanoma, metastatic to lymphnode, skin .a 4729 to 5195 477 to 11   AAA   467/467
(100 %)
0 diff
(100 %id)
AI911303 pooled .a 4731 to 5202 474 to 4       471/474
(99 %)
0 diff
(100 %id)
AA640010 normal prostate, Prostate .a 4734 to 5196 460 to 1       460/460
(100 %)
7 diff
(98.5 %id)
AI057020 B-cell, chronic lymphotic leukemia .a 4737 to 5192 464 to 9       456/464
(98 %)
0 diff
(100 %id)
AI982659 adenocarcinoma, Pancreas .a 4737 to 5199 463 to 1       463/463
(100 %)
1 diff
(99.8 %id)
DB319786   .a 4738 to 5191 456 to 1       456/461
(98 %)
10 diff
(97.9 %id)
AI269588 pooled .a 4738 to 5202 466 to 2       465/466
(99 %)
0 diff
(100 %id)
AI355209 esophagus, squamous cell carcinoma .a 4738 to 5225 487 to 1       487/487
(100 %)
2 diff
(99.6 %id)
AI651330 Kidney .a 4738 to 5192 461 to 7       455/461
(98 %)
0 diff
(100 %id)
AI199530 anaplastic oligodendroglioma, brain .a 4740 to 5192 457 to 4       454/457
(99 %)
0 diff
(100 %id)
AA927909 pooled .a 4745 to 5192 455 to 6       450/459
(98 %)
0 diff
(100 %id)
AA831743 germinal center B cell .a 4750 to 5191 454 to 14   AAA   441/441
(100 %)
7 diff
(98.5 %id)
AI612753 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4751 to 5192 450 to 9       442/450
(98 %)
0 diff
(100 %id)
BQ072965 leukocyte .a 4758 to 5192 9 to 441       433/1270
(34 %)
4 diff
(99.7 %id)
AA043504 uterus .a 4762 to 5203 433 to 1   fully sequenced,   433/433
(100 %)
6 diff
(98.7 %id)
BG991102 head_neck .a 4764 to 5010 1 to 246       246/294
(83 %)
17 diff
(94.3 %id)
BG057358 blood, lymphocyte .a 4766 to 5192 441 to 15       427/441
(96 %)
0 diff
(100 %id)
AW613213 2 pooled high-grade transitional celltumors, genitourinary tract .a 4767 to 5192 434 to 9       426/434
(98 %)
0 diff
(100 %id)
BG236320 blood, lymphocyte .a 4767 to 5229 476 to 14   tiling clone, AAA   463/463
(100 %)
0 diff
(100 %id)
AW299539 Kidney .a 4768 to 5191 437 to 14   AAA   424/424
(100 %)
0 diff
(100 %id)
AW299892 Kidney .a 4768 to 5191 437 to 14   AAA   424/424
(100 %)
6 diff
(98.6 %id)
AW188293 pooled .a 4769 to 5198 451 to 22   AAA   430/430
(100 %)
13 diff
(97.0 %id)
BE676286 B-cell, chronic lymphotic leukemia .a 4769 to 5195 446 to 20   AAA   427/427
(100 %)
6 diff
(98.6 %id)
BE910359 epithelioid carcinoma, Pancreas .a 4770 to 5192 1 to 423       423/427
(99 %)
1 diff
(99.8 %id)
BE908413 epithelioid carcinoma, Pancreas .a 4772 to 5191 1 to 421       421/426
(98 %)
2 diff
(99.6 %id)
BQ548760 insulinoma, Pancreas .a 4779 to 5139 361 to 1   fully sequenced,   361/361
(100 %)
2 diff
(99.5 %id)
BI711372 insulinoma, Pancreas .a 4782 to 5214 433 to 1   fully sequenced,   433/433
(100 %)
8 diff
(98.2 %id)
BM510537 insulinoma, Pancreas .a 4786 to 5214 429 to 1   fully sequenced,   429/429
(100 %)
8 diff
(98.2 %id)
BU070337 insulinoma, Pancreas .a 4787 to 5214 428 to 1   fully sequenced,   428/428
(100 %)
8 diff
(98.2 %id)
AA441849   .a 4788 to 5177 15 to 400       386/400
(96 %)
6 diff
(98.5 %id)
AI174613   .a 4788 to 5191 432 to 30   AAA   403/403
(100 %)
19 diff
(95.3 %id)
BQ614246 insulinoma, Pancreas .a 4788 to 5214 428 to 1   fully sequenced,   428/428
(100 %)
9 diff
(97.9 %id)
BU070343 insulinoma, Pancreas .a 4791 to 5212 422 to 1   fully sequenced,   422/422
(100 %)
8 diff
(98.2 %id)
AI445715 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4798 to 5191 394 to 1       394/394
(100 %)
4 diff
(99.0 %id)
BM975689 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 4802 to 5198 415 to 19   AAA   397/397
(100 %)
0 diff
(100 %id)
BQ026036 placenta .a 4805 to 5199 412 to 18   AAA   395/395
(100 %)
4 diff
(99.0 %id)
BG231933 blood, lymphocyte .a 4806 to 5191 398 to 14   AAA   385/385
(100 %)
1 diff
(99.8 %id)
AI401758 Prostate .a 4812 to 5191 380 to 1       380/380
(100 %)
0 diff
(100 %id)
CF530074 placenta .a 4812 to 5020 227 to 19   AAA   209/209
(100 %)
0 diff
(100 %id)
BM673527 eye, human retina .a 4813 to 5198 404 to 19   AAA   386/386
(100 %)
5 diff
(98.8 %id)
BM988739 lung, Lung Focal Fibrosis .a 4815 to 5198 402 to 19   AAA   384/384
(100 %)
0 diff
(100 %id)
BQ011510 placenta .a 4815 to 5020 224 to 19   AAA   206/206
(100 %)
0 diff
(100 %id)
AU156203 placenta .a 4818 to 5229 412 to 1       412/412
(100 %)
3 diff
(99.3 %id)
AU157919 placenta .a 4818 to 5229 412 to 1       412/412
(100 %)
9 diff
(97.9 %id)
DB372707 placenta .a 4820 to 5229 412 to 1       412/414
(99 %)
29 diff
(93.0 %id)
AA127523 lung, lung carcinoma .a 4836 to 5191 1 to 362   fully sequenced,   362/362
(100 %)
4 diff
(98.9 %id)
BF222233 Prostate .a 4837 to 5192 359 to 4       356/359
(99 %)
0 diff
(100 %id)
AI826202 normal prostate, Prostate .a 4838 to 5192 358 to 3       356/358
(99 %)
0 diff
(100 %id)
AI971183 Prostate .a 4838 to 5192 359 to 5       355/359
(98 %)
0 diff
(100 %id)
BF448561 fibrotheoma, ovary .a 4844 to 5192 355 to 8       348/355
(98 %)
0 diff
(100 %id)
AI356171 anaplastic oligodendroglioma, brain .a 4849 to 5192 344 to 1       344/344
(100 %)
0 diff
(100 %id)
AA960979 pooled .a 4852 to 5195 344 to 1       344/344
(100 %)
2 diff
(99.5 %id)
AA126800 uterus .a 4853 to 5198 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
AA515384 colon .a 4853 to 5197 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AI394691 B-cell, chronic lymphotic leukemia .a 4856 to 5191 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AW015639   .a 4856 to 5247 391 to 1   tiling clone,   391/391
(100 %)
8 diff
(98.0 %id)
R69871 placenta .a 4857 to 5201 350 to 1   fully sequenced,   350/350
(100 %)
10 diff
(97.2 %id)
N92933 lung .a 4859 to 5020 186 to 26   AAA   161/161
(100 %)
2 diff
(98.8 %id)
AI868959 Prostate .a 4860 to 5192 337 to 5       333/337
(98 %)
0 diff
(100 %id)
AI691138 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4863 to 5024 161 to 1       161/167
(96 %)
0 diff
(100 %id)
BF339878 brain, glioblastoma with EGFR amplification .a 4864 to 5198 1 to 334   AAA   334/334
(100 %)
2 diff
(99.5 %id)
BF684637 leiomyosarcoma cell line, uterus .a 4866 to 5198 1 to 333   AAA   333/333
(100 %)
2 diff
(99.4 %id)
BF686747 leiomyosarcoma cell line, uterus .a 4866 to 5197 1 to 330   AAA   330/330
(100 %)
6 diff
(98.2 %id)
BG820067 anaplastic oligodendroglioma with 1p/19qloss, brain .a 4866 to 5024 1 to 158   AAA   158/158
(100 %)
1 diff
(99.4 %id)
BM670669 eye, fetal eyes .a 4866 to 5215 350 to 1   fully sequenced,   350/350
(100 %)
9 diff
(97.5 %id)
AW571954 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 4869 to 5212 345 to 1       345/345
(100 %)
2 diff
(99.5 %id)
AW105561 ovary, tumor, 5 pooled (see description) .a 4877 to 5198 323 to 1       323/323
(100 %)
2 diff
(99.4 %id)
BM510806 insulinoma, Pancreas .a 4892 to 5214 323 to 1   fully sequenced,   323/323
(100 %)
8 diff
(97.6 %id)
AA693495   .a 4898 to 5016 119 to 1       119/119
(100 %)
3 diff
(97.5 %id)
AA809947 germinal center B cell .a 4899 to 5000 102 to 1       102/102
(100 %)
0 diff
(100 %id)
AA995443 germ cell tumor .a 4900 to 5021 124 to 3       122/124
(98 %)
0 diff
(100 %id)
AI475434 colon, moderately-differentiated adenocarcinoma .a 4901 to 5198 312 to 15   AAA   298/298
(100 %)
0 diff
(100 %id)
AI623347 adenocarcinoma, Pancreas .a 4905 to 5197 319 to 26   AAA   294/298
(98 %)
4 diff
(98.7 %id)
AA936000 Kidney, kidney tumor .a 4908 to 5191 306 to 23   AAA   284/284
(100 %)
0 diff
(100 %id)
AI783757 Prostate .a 4909 to 5185 293 to 18       276/293
(94 %)
0 diff
(100 %id)
BE503780 carcinoid, lung .a 4925 to 5192 275 to 8       268/275
(97 %)
0 diff
(100 %id)
BM999686 lung, Lung Focal Fibrosis .a 4931 to 5198 286 to 19   AAA   268/268
(100 %)
7 diff
(97.4 %id)
AW029322 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4955 to 5191 237 to 1       237/237
(100 %)
0 diff
(100 %id)
AI886638 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 4957 to 5198 261 to 20   AAA   242/242
(100 %)
6 diff
(97.6 %id)
AI758414 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 4958 to 5191 234 to 1       234/234
(100 %)
0 diff
(100 %id)
AI766784 2 pooled tumors (clear cell type), Kidney .a 4963 to 5191 248 to 18   AAA   231/231
(100 %)
2 diff
(99.2 %id)
AI886221 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4969 to 5192 227 to 3       225/227
(99 %)
0 diff
(100 %id)
BE552017 pooled germ cell tumors .a 4981 to 5229 269 to 21   AAA   249/249
(100 %)
1 diff
(99.6 %id)
T39711 fetal spleen, Spleen .a 4983 to 5177 1 to 194       194/194
(100 %)
5 diff
(97.5 %id)
D20348   .a 4992 to 5192 1 to 201     Submitted on the opposite strand 201/203
(99 %)
1 diff
(99.6 %id)
AW083692 esophagus, squamous cell carcinoma .a 5005 to 5191 208 to 22   AAA   187/187
(100 %)
0 diff
(100 %id)
AA127500 lung, lung carcinoma .a 5010 to 5197 188 to 1   fully sequenced,   188/188
(100 %)
4 diff
(97.9 %id)
AA988088 carcinoid, lung .a 5017 to 5153 137 to 1       137/137
(100 %)
0 diff
(100 %id)
AA988099 carcinoid, lung .a 5017 to 5191 190 to 16   AAA   175/175
(100 %)
0 diff
(100 %id)
BE670325 carcinoid, lung .a 5018 to 5191 193 to 20   AAA   174/174
(100 %)
1 diff
(99.5 %id)
T17454   .a 5024 to 5229 206 to 1       206/206
(100 %)
0 diff
(100 %id)
AA026144 uterus .a 5030 to 5198 169 to 1       169/171
(98 %)
0 diff
(100 %id)
AI915012 ovary, tumor, 5 pooled (see description) .a 5036 to 5202 167 to 1       167/167
(100 %)
0 diff
(100 %id)
F23504 pectoral muscle (after mastectomy) .a 5128 to 5199 1 to 72       72/72
(100 %)
4 diff
(94.5 %id)
N77610 liver and spleen .b 1 to 514 1 to 510   tiling clone,   510/511
(99 %)
6 diff
(98.9 %id)
CN281979 embryonic stem cells, cell lines H1, H7, andH9 .b 87 to 551 1 to 465   tiling clone,   465/465
(100 %)
3 diff
(99.4 %id)
L36818   .b 480 to 5135 1 to 4654 R56P L80P E84* tiling clone,   4654/4657
(99 %)
14 diff
(99.7 %id)
AI469991 pooled .b 5102 to 5579 1 to 478     Submitted on the opposite strand 478/478
(100 %)
6 diff
(98.8 %id)
CN264450 embryonic stem cells, cell lines H1, H7, andH9 .b 5107 to 5361 61 to 315       255/325
(78 %)
2 diff
(99.4 %id)
DB294960   .b 5108 to 5646 1 to 539   tiling clone, Submitted on the opposite strand 539/539
(100 %)
0 diff
(100 %id)
BE047083 squamous cell carcinoma, tongue .b 5109 to 5561 10 to 462     Submitted on the opposite strand 453/462
(98 %)
6 diff
(98.8 %id)
BX331693 Neuroblastoma Cot 25-normalized .b 5111 to 5855 1 to 744     Submitted on the opposite strand 744/747
(99 %)
26 diff
(96.6 %id)
BE047074 squamous cell carcinoma, tongue .b 5112 to 5525 1 to 414     Submitted on the opposite strand 414/414
(100 %)
0 diff
(100 %id)
DB357082 whole embryo, mainly head .b 5113 to 5670 1 to 554     Submitted on the opposite strand 554/574
(96 %)
13 diff
(97.8 %id)
BX351051 Neuroblastoma Cot 25-normalized .b 5116 to 5593 1 to 479     Submitted on the opposite strand 479/523
(91 %)
31 diff
(94.1 %id)
BX372826 Neuroblastoma Cot 25-normalized .b 5116 to 5716 1 to 609     Submitted on the opposite strand 609/630
(96 %)
37 diff
(94.2 %id)
BX392354 Neuroblastoma Cot 25-normalized .b 5116 to 5534 1 to 420     Submitted on the opposite strand 420/437
(96 %)
3 diff
(99.4 %id)
BX392237 Neuroblastoma Cot 25-normalized .b 5118 to 5669 7 to 558     Submitted on the opposite strand 552/592
(93 %)
28 diff
(95.3 %id)
BG683691 brain, neuroblastoma, cell line .b 5118 to 5940 1 to 823     Submitted on the opposite strand 823/824
(99 %)
26 diff
(96.9 %id)
BX351261 Neuroblastoma Cot 50-normalized .b 5121 to 5830 1 to 706     Submitted on the opposite strand 706/783
(90 %)
8 diff
(99.0 %id)
BX331407 Neuroblastoma Cot 10-normalized .b 5127 to 6163 1 to 1035   tiling clone, Submitted on the opposite strand 1035/1077
(96 %)
27 diff
(97.5 %id)
AL525460 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 5128 to 6170 1 to 1040   tiling clone, Submitted on the opposite strand 1040/1074
(96 %)
20 diff
(98.2 %id)
AL529553 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 5132 to 6221 1 to 1082   tiling clone, Submitted on the opposite strand 1082/1082
(100 %)
21 diff
(98.1 %id)
AL529570 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 5134 to 6237 1 to 1102   tiling clone, Submitted on the opposite strand 1102/1102
(100 %)
60 diff
(94.6 %id)
BX354725 Neuroblastoma Cot 25-normalized .b 5139 to 5859 1 to 721     Submitted on the opposite strand 721/721
(100 %)
12 diff
(98.4 %id)
BX375719 Neuroblastoma Cot 25-normalized .b 5140 to 5671 1 to 530     Submitted on the opposite strand 530/557
(95 %)
7 diff
(98.8 %id)
BX352907 Neuroblastoma Cot 10-normalized .b 5144 to 6057 1 to 913     Submitted on the opposite strand 913/940
(97 %)
21 diff
(97.8 %id)
BX354147 Neuroblastoma Cot 25-normalized .b 5146 to 6179 1 to 1035   tiling clone, Submitted on the opposite strand 1035/1035
(100 %)
15 diff
(98.6 %id)
BG683832 brain, neuroblastoma, cell line .b 5162 to 5993 1 to 832     Submitted on the opposite strand 832/832
(100 %)
30 diff
(96.4 %id)
BX365821 Neuroblastoma Cot 10-normalized .b 5164 to 5927 18 to 789     Submitted on the opposite strand 772/789
(97 %)
6 diff
(99.3 %id)
BX402163 Neuroblastoma Cot 25-normalized .b 5183 to 6025 63 to 908     Submitted on the opposite strand 846/908
(93 %)
6 diff
(99.4 %id)
AL522063 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 5190 to 6035 75 to 920     Submitted on the opposite strand 846/920
(91 %)
6 diff
(99.4 %id)
AL523033 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 5208 to 5958 81 to 831     Submitted on the opposite strand 751/831
(90 %)
9 diff
(99.0 %id)
BQ888327 epidermoid carcinoma, cell line, lung .c 1 to 747 1 to 757   tiling clone,   757/933
(81 %)
13 diff
(98.7 %id)
TI_57177081   .c 583 to 1384 64 to 864   tiling clone,   801/864
(92 %)
24 diff
(97.3 %id)
DB140817 thymus .c 995 to 1528 2 to 535   tiling clone, capped   534/534
(100 %)
0 diff
(100 %id)
BP353600   .c 1228 to 1816 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
CV316373 testis_normal .c 1367 to 1487 119 to 1     Submitted on the opposite strand 119/120
(99 %)
4 diff
(96.7 %id)
BP280566   .c 1386 to 1977 1 to 588   tiling clone,   588/588
(100 %)
6 diff
(99.0 %id)
CN276749 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1431 to 1684 1 to 254       254/254
(100 %)
1 diff
(99.7 %id)
BI051871 placenta_normal .c 1681 to 1969 48 to 337   tiling clone,   290/337
(86 %)
7 diff
(98.0 %id)
BM719193 eye, fetal eye .c 1943 to 2641 1 to 699   tiling clone,   699/699
(100 %)
0 diff
(100 %id)
CR992820 T-Lymphocytes .c 1985 to 2574 1 to 590       590/595
(99 %)
3 diff
(99.5 %id)
BI523616 pooled lung and spleen .c 2067 to 2804 1 to 737   tiling clone,   737/737
(100 %)
2 diff
(99.8 %id)
TI_44159121   .c 2067 to 2804 34 to 770       737/770
(95 %)
8 diff
(99.0 %id)
DA621718 Kidney .c 2069 to 2606 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
BQ880643 brain, neuroblastoma, cell line .d 1 to 925 24 to 952   tiling clone,   929/953
(97 %)
14 diff
(98.6 %id)
BM463382 embryonal carcinoma, cell line, testis .d 171 to 971 1 to 805       805/992
(81 %)
13 diff
(98.7 %id)
CX871402 embryonic stem .d 262 to 939 1 to 678   tiling clone,   678/678
(100 %)
0 diff
(100 %id)
CN279245 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 346 to 950 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BE264871 lung, small cell carcinoma .d 363 to 950 1 to 586       586/588
(99 %)
4 diff
(99.4 %id)
CN279243 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 379 to 950 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BQ084041 stomach .d 495 to 923 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
BE792570 lung, small cell carcinoma .d 700 to 1416 1 to 715   tiling clone,   715/715
(100 %)
2 diff
(99.8 %id)
CN279222 embryonic stem cells, DMSO-treated H9 cellline .d 946 to 1430 1 to 486   tiling clone,   486/486
(100 %)
6 diff
(98.8 %id)
BQ932403 sciatic nerve .e 1 to 804 1 to 804 E136X F137V Y164I K165Q P191A ... tiling clone,   906/1047
(86 %)
21 diff
(98.0 %id)
CD172223 White Matter .f 1 to 803 1 to 810 exact tiling clone,   810/883
(91 %)
9 diff
(99.0 %id)
AW250368 lung, small cell carcinoma .f 77 to 377 10 to 310       301/310
(97 %)
0 diff
(100 %id)
BE266833 lung, small cell carcinoma .f 163 to 726 1 to 569       569/570
(99 %)
11 diff
(98.1 %id)
CN485273 eye .f 250 to 799 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BX095142 breast .f 571 to 1219 26 to 675   tiling clone,   648/675
(96 %)
6 diff
(99.2 %id)
R52290 breast .f 571 to 938 1 to 369       369/369
(100 %)
2 diff
(99.5 %id)
AW250964 lung, small cell carcinoma .f 1044 to 1450 408 to 1   tiling clone,   408/408
(100 %)
8 diff
(98.1 %id)
R52291 breast .f 1097 to 1428 341 to 10       332/347
(95 %)
0 diff
(100 %id)
AA286736 germinal center B cell .g 1 to 505 1 to 506   tiling clone,   506/506
(100 %)
2 diff
(99.7 %id)
BF924636 nervous_tumor .g 656 to 1001 1 to 346   tiling clone,   346/346
(100 %)
1 diff
(99.8 %id)
AA287610 germinal center B cell .g 671 to 814 141 to 1   tiling clone,   141/145
(97 %)
0 diff
(100 %id)
AW167082 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 1 to 475 1 to 475 P88X tiling clone, Submitted on the opposite strand 475/475
(100 %)
1 diff
(99.8 %id)
AI140922 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 3 to 361 1 to 354     Submitted on the opposite strand 354/354
(100 %)
8 diff
(97.8 %id)
AA805744 germinal center B cell .h 74 to 531 1 to 457   tiling clone, Submitted on the opposite strand 457/457
(100 %)
6 diff
(98.7 %id)
BI604235 brain, hypothalamus .i 1 to 481 527 to 29   tiling clone, Submitted on the opposite strand 499/1041
(47 %)
8 diff
(99.3 %id)
TI_45211618   .i 1 to 481 527 to 29     Submitted on the opposite strand 499/1041
(47 %)
8 diff
(99.3 %id)
CN482407 eye .i 268 to 817 1 to 550 exact tiling clone,   550/550
(100 %)
0 diff
(100 %id)
TI_153987713   .j 1 to 372 472 to 101 exact tiling clone, AAA   372/372
(100 %)
0 diff
(100 %id)
AW204049   .j 21 to 372 369 to 18   AAA   352/352
(100 %)
0 diff
(100 %id)
AI341923 pooled germ cell tumors .j 37 to 372 346 to 11   AAA   336/336
(100 %)
0 diff
(100 %id)
DA318050 hippocampus .k 1 to 546 2 to 547 exact tiling clone, capped   546/546
(100 %)
0 diff
(100 %id)
BU501574 brain, neuroblastoma, cell line .l 1 to 617 63 to 684   tiling clone,   622/1107
(56 %)
27 diff
(97.6 %id)
BQ956853 brain, neuroblastoma, cell line .l 3 to 833 1 to 836   tiling clone,   836/918
(91 %)
25 diff
(97.3 %id)
BG120649 adenocarcinoma, cell line, Liver .l 238 to 462 1 to 222       222/222
(100 %)
3 diff
(98.7 %id)
TI_153962544   .l 812 to 1007 108 to 304 E9D V15D G22R C28S G52V ... tiling clone,   489/1006
(48 %)
38 diff
(96.3 %id)
CR986429 T-Lymphocytes .m-u 1 to 492 1 to 493 exact tiling clone,   493/493
(100 %)
2 diff
(99.6 %id)
BQ949698 sciatic nerve .m-u 276 to 946 12 to 690   tiling clone,   679/989
(68 %)
12 diff
(98.8 %id)
BQ694016 adipose .m-u 556 to 992 1 to 437   tiling clone,   437/437
(100 %)
1 diff
(99.8 %id)
CX865330 embryonic stem .n-u 1 to 641 1 to 641 exact tiling clone,   641/641
(100 %)
1 diff
(99.9 %id)
AI356293 B-cell, chronic lymphotic leukemia .o 1 to 375 375 to 1 exact tiling clone,   375/375
(100 %)
0 diff
(100 %id)
AI796166 Kidney .p 1 to 275 276 to 2 exact tiling clone,   275/276
(99 %)
0 diff
(100 %id)
BQ327117 colon_normal .q-u 1 to 272 299 to 25 exact tiling clone,   275/310
(88 %)
0 diff
(100 %id)
DB309744 hippocampus Gene INPPL1, variant not shown         This clone was ignored    
DA332735 hippocampus Gene INPPL1, variant not shown       capped This clone was ignored    
CN279227 embryonic stem cells, DMSO-treated H9 cellline Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
CN279236 embryonic stem cells, cell lines H1, H7, andH9 Gene INPPL1, variant not shown         This clone was ignored    
BX418522 brain, fetal brain Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
AU099287   Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
BP254730 Kidney Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
CN481062 eye Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
CN483528 eye Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
AA855029 parathyroid gland, parathyroid tumor Gene INPPL1, variant not shown         Submitted on the opposite strand    
AA994024 pooled Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
AI432128 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
BF111505 pooled Gene INPPL1, variant not shown         Submitted on the opposite strand    
BE408413 choriocarcinoma, placenta Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
BF197603 Kidney Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
CB123428 Liver Gene INPPL1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_149314182   Gene INPPL1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CB321692 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene INPPL1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n-u, .o, .p, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI